| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |